Chan, Samuel K. W., Hill, Mark E., Gullick, William J. (2006) The role of the epidermal growth factor receptor in breast cancer. Journal of Mammary Gland Biology and Neoplasia, 11 (1). pp. 3-11. ISSN 1083-3021. (doi:10.1007/s10911-006-9008-2) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:3971)
|
PDF (The Role of the Epidermal Growth Factor Receptor)
Language: English Restricted to Repository staff only |
|
|
|
![[thumbnail of The Role of the Epidermal Growth Factor Receptor]](https://kar.kent.ac.uk/style/images/fileicons/application_pdf.png) |
| Official URL: http://dx.doi.org/10.1007/s10911-006-9008-2 |
|
Abstract
Recent trials of drug therapy targeting the erbB receptor HER2 have met with success in breast cancer. The epidermal growth factor receptor or EGFR is a closely related receptor from this same family that is involved in cellular signal transduction and tumor cell growth and survival. Emerging evidence indicates that EGFR is implicated in the development of hormone-resistant breast cancer, and that its activity is intertwined with estrogen receptor. Here, the role of EGFR in breast cancer is reviewed, and data from selected clinical trials of signal transduction inhibition of this cellular target are summarized.
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.1007/s10911-006-9008-2 |
| Uncontrolled keywords: | Breast - ErbB - EGFR - Signal transduction - Hormone resistance - Gefitinib - Erlotinib |
| Subjects: |
Q Science R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology |
| Divisions: | Divisions > Division of Natural Sciences > Biosciences |
| Depositing User: | William Gullick |
| Date Deposited: | 30 Aug 2008 20:43 UTC |
| Last Modified: | 16 Nov 2021 09:42 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/3971 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):
Altmetric
Altmetric
